170 related articles for article (PubMed ID: 20034139)
1. FDA notifications. New pediatric guidelines by NIH, CDC.
AIDS Alert; 2009 Oct; 24(10):117-8. PubMed ID: 20034139
[No Abstract] [Full Text] [Related]
2. FDA notifications. Pediatric HIV infection guidelines for use of ARTs are revised.
AIDS Alert; 2008 Apr; 23(4):46-7. PubMed ID: 19255980
[No Abstract] [Full Text] [Related]
3. FDA notifications. Pediatric HIV infection guidelines updated.
AIDS Alert; 2005 Jul; 20(7):83. PubMed ID: 16110564
[No Abstract] [Full Text] [Related]
4. FDA notifications. New antiretroviral guidelines issued.
AIDS Alert; 2005 Jan; 20(1):11-2. PubMed ID: 15717358
[No Abstract] [Full Text] [Related]
5. FDA notifications. ART guidelines for adults & adolescents are revised.
AIDS Alert; 2010 Jan; 25(1):10-12. PubMed ID: 20143504
[No Abstract] [Full Text] [Related]
6. FDA notifications. DHHS panel releases new ART guidelines.
AIDS Alert; 2011 Mar; 26(3):34-5. PubMed ID: 21539042
[No Abstract] [Full Text] [Related]
7. FDA notifications. Revised guidelines for pregnant women.
AIDS Alert; 2007 Dec; 22(12):141. PubMed ID: 18411483
[No Abstract] [Full Text] [Related]
8. FDA notifications. Pediatric HIV infection guidelines are revised.
AIDS Alert; 2008 Oct; 23(10):114-5. PubMed ID: 18935684
[No Abstract] [Full Text] [Related]
9. FDA notifications. Changes to ART guidelines detailed by the FDA.
AIDS Alert; 2008 Mar; 23(3):33-4. PubMed ID: 18663777
[No Abstract] [Full Text] [Related]
10. FDA notifications. Adult treatment guidelines updated.
AIDS Alert; 2005 Nov; 20(11):130-1. PubMed ID: 16363050
[No Abstract] [Full Text] [Related]
11. FDA guidelines revised for combination HIV therapies.
AIDS Policy Law; 2004 Jun; 19(10):2. PubMed ID: 15202412
[No Abstract] [Full Text] [Related]
12. CDC issues guidelines on treating OIs among adults. ART is cornerstone of treatment plan.
AIDS Alert; 2005 Jun; 20(6):66-8. PubMed ID: 15962431
[TBL] [Abstract][Full Text] [Related]
13. National AIDS conference focuses on front lines of prevention, treatment.
AIDS Policy Law; 2003 Apr; 18(7):1, 4. PubMed ID: 12728843
[No Abstract] [Full Text] [Related]
14. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy.
Cohen J
Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490
[No Abstract] [Full Text] [Related]
15. CDC post-exposure guidelines: what providers and management need to know.
West K
Emerg Med Serv; 2001 Oct; 30(10):57-63. PubMed ID: 11680219
[No Abstract] [Full Text] [Related]
16. FDA notifications. FDA provides important information for clinicians serving hurricane victims.
AIDS Alert; 2005 Nov; 20(11):129. PubMed ID: 16363049
[No Abstract] [Full Text] [Related]
17. New guidelines issued for occupational exposures.
AIDS Policy Law; 1998 May; 13(10):10. PubMed ID: 11365445
[TBL] [Abstract][Full Text] [Related]
18. AmFAR extols FDA on rapid approval of two protease inhibitors.
AIDS Patient Care STDS; 1996 Jun; 10(3):193-4. PubMed ID: 11361645
[No Abstract] [Full Text] [Related]
19. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
AIDS Alert; 2006 Jan; 21(1):11-2. PubMed ID: 16470945
[No Abstract] [Full Text] [Related]
20. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
